NAUT today
$2.38-$0.04 (-1.65%)close Nov 12, 2026Trend
DailyUptrend (confirmed)
4 hourStrong Bullish
1 hourStrong Bearish
15 minStrong Bearish
5 minExpanding
Daily trend turns down below $2.17
Key levels
Resistance$3.03
Resistance$2.54
Support$1.99
Support$1.57
Latest news & SEC filings
AnalystNautilus Biotechnology price target lifted by Roth Capital analyst
EarningsNautilus Biotechnology holds Q3 2026 earnings call
EarningsNautilus Biotechnology Posts Q3 2026 Financials
NewsNautilus Biotechnology added to ARPA-H-backed SEEDS research group
All NAUT news →About Nautilus Biotechnology
Nautilus Biotechnology is an early-stage life sciences firm creating technology to quantify proteins on a large scale. Its Nautilus Voyager platform applies a technique called Iterative Mapping to examine individual protein molecules, with the goal of enabling both wide protein surveys and detailed analysis of protein variants. The company works with biopharma companies, academic labs, and research organizations through partnerships and a planned fee-for-service model.
Based on the company's 10-K filed Feb 26, 2026.
Nasdaq · Technology
Nautilus Biotechnology, Inc. (NAUT)
What Is the Price Target for NAUT?
SEPT Low Target
$2.98
SEPT Mid Target
$3.50
SEPT High Target
$4.02
Analyst Consensus
$3.50
Is NAUT a Buy or Sell Right Now?
Thesis
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for NAUT.
Start Free Trial →Is NAUT Overvalued or Undervalued?
Valuation Verdict
FAIR
Methods Used
P/B, Analyst Consensus
Fair Value
$3.37
17
Moat Score
NONE
1/9
Piotroski Score
4.6
Altman Z-Score
What Is Smart Money Doing with NAUT?
Insider Signal
NEUTRAL
1 buys / 2 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
ACCUMULATING
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| AH Equity Partners Bio II, L.L.C. | 10% owner | Sale | 4,615,974 | $10.8M | Jun 2, 2026 |
| AH Equity Partners Bio II, L.L.C. | 10% owner | Sale | 384,026 | $902K | Jun 2, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →NAUT Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
16.07%
FCF Growth YoY
15.2%
Revenue Trend
UNKNOWN
Dark Pool Trades for NAUT
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for NAUT, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 24:33:24 | $2.37 | 2,000 | $$5K | SELL |
| 24:00:58 | $2.39 | 1,800 | $$4K | BUY |
| 24:00:10 | $2.39 | 3,600 | $$9K | BUY |
| 23:57:55 | $2.39 | 2,000 | $$5K | BUY |
| 23:57:55 | $2.39 | 1,000 | $$2K | BUY |
5 dark pool trades shown · $$25K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for NAUT
PREVIEWSEPT Investing provides real-time options flow tracking for NAUT, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| PUT | $2.5 | Nov 20 | 8 | $$30 | 1 | SWEEP |
| CALL | $2.5 | Dec 18 | 36 | $$3000 | 100 | BLOCK |
2 options trades shown · 50% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Nautilus Biotechnology, Inc. (NAUT) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (6 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →NAUT — frequently asked questions
What is NAUT stock price today?
Nautilus Biotechnology, Inc. (NAUT) is at $2.38, down 1.65% (-$0.04) at the Nov 12, 2026 close.
Why is NAUT stock moving today?
Latest NAUT news — Oct 29, 2026: Nautilus Biotechnology price target lifted by Roth Capital analyst · Oct 27, 2026: Nautilus Biotechnology holds Q3 2026 earnings call
What is the NAUT price target?
The average analyst price target for NAUT is $3.50, ranging from $4 to $4, based on 3 analysts. Latest: Nautilus Biotechnology upgrade on Sep 29, 2026.
What do analysts rate NAUT?
Analyst ratings for NAUT: 0 Buy, 4 Hold, 0 Sell — consensus Hold.
Did NAUT beat earnings?
NAUT last reported on Oct 27, 2026: EPS -$0.12 vs -$0.14 expected — a beat of 14.3%.
Does NAUT pay a dividend?
NAUT does not currently pay a dividend.
What are NAUT support and resistance levels?
Support: $1.99, $1.57, $0.90. Resistance: $2.54, $3.03, $3.42.
What are insiders doing with NAUT?
Insider activity: NEUTRAL, 1 buys and 2 sells in the last 90 days.
What is the latest news on NAUT?
Oct 29, 2026: Nautilus Biotechnology price target lifted by Roth Capital analyst · Oct 27, 2026: Nautilus Biotechnology holds Q3 2026 earnings call · Oct 27, 2026: Nautilus Biotechnology Posts Q3 2026 Financials